Johnson & Johnson (JNJ) insider trading and SEC filings
JOHNSON & JOHNSON · NYSE · Pharmaceutical Preparations
Company facts
What Johnson & Johnson tells the SEC about itself on the same registration record these filings come from.
- Industry (SIC) — Pharmaceutical Preparations
- Exchange — NYSE
- Filer category — Large accelerated filer
- Fiscal year end — January 3
- State of incorporation — New Jersey
- Former names — JOHNSON & JOHNSON ET AL (1995-1996)
JNJ insider transactions
Officers, directors and 10% owners must tell the SEC when they buy or sell Johnson & Johnson stock, within two business days. These are the most recent, straight from EDGAR.
I read the 8 insider filings below, filed between Aug 7 and Sep 10, 2026, on Forms 3 and 4. Each one is about Johnson & Johnson stock and links to the original on EDGAR. They name 7 insiders: 3 directors and 4 officers. Of the filings, 4 report an open-market sale and 3 an option exercise (some filings report more than one type). In 3 of the 4 filings reporting a sale, the same person also reports an option exercise on the same trade date. Johnson & Johnson's SEC record shows its latest 10-K filed Feb 11, 2026, its latest 10-Q Jul 23, 2026, and its latest 8-K Aug 4, 2026.
| Form | Filed | Insider | Transaction | Price | Trade date | Shares held after | Ownership | |
|---|---|---|---|---|---|---|---|---|
| 4 | 2026-09-10 | Pinto Daniel E — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-10 | Woods Eugene A. — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-10 | HEWSON MARILLYN A — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-09-04 | Timothy Schmid — EVP, WW Chair, MedTech | Option exercise · 33,597 shares across 2 transactions | $131.94-$151.41 | Sep 2, 2026 | 47,974 | Direct | Filing |
| Open-market sale · 33,597 shares across 2 transactions | $274.74 | Sep 2, 2026 | 25,447 | Direct | ||||
| 3 | 2026-09-01 | Thomas Cavanaugh — EVP WW Chair, Innovative Med. | Initial statement of holdings | — | — | — | — | Filing |
| 4 | 2026-08-18 | Taubert Jennifer L — EVP, WWC. Innovative Medicine | Option exercise · 15,000 shares | $115.67 | Aug 17, 2026 | 209,451 | Direct | Filing |
| Open-market sale · 15,000 shares | $263.36 | Aug 17, 2026 | 194,451 | Direct | ||||
| 4 | 2026-08-14 | Joaquin Duato — CEO and Chairman of the Board | Option exercise · 123,291 shares | $115.67 | Aug 13, 2026 | 399,258 | Direct | Filing |
| Open-market sale · 123,291 shares across 2 transactions | $261.00-$262.00 | Aug 13, 2026 | 275,967 | Direct | ||||
| 4 | 2026-08-07 | Joaquin Duato — CEO and Chairman of the Board | Open-market sale · 48,480 shares across 2 transactions | $258.056-$258.739 | Aug 5, 2026 | 275,967 | Direct | Filing |
Transaction wording follows the code on the filing itself — what each Form 4 code means. An option exercise or a tax withholding is not a market decision, and is not shown as one.
- Form 3 — Someone became an insider and declared their holdings
- Form 4 — An insider bought or sold company stock
Get JNJ's filings, read.
Other recent Johnson & Johnson filings
| Form | Filed | Document |
|---|---|---|
| 8-K | 2026-08-04 | 8-K |
| 8-K | 2026-07-29 | 8-K |
| 8-K | 2026-07-28 | 8-K |
| 10-Q | 2026-07-23 | 10-Q |
| 8-K | 2026-07-15 | 8-K |
| 8-K | 2026-04-28 | 8-K |
| 10-Q | 2026-04-22 | 10-Q |
| 10-K | 2026-02-11 | 10-K |
Reading these accurately
A Form 4 records what happened, precisely and on the record — it has no field for why. A sale can be scheduled months in advance under a Rule 10b5-1 plan, and vesting and option exercises appear alongside open-market decisions. The fuller version is in what insider buying and selling actually signals; to look up any other company, use the insider filing tracker.
Insider filings for other companies
Companies filing in the same sector, and other names Pip tracks.